ES2063796T3 - Nuevos derivados de 2'-halometiliden, 2'-eteniliden- y 2'-etinil-adenosina. - Google Patents

Nuevos derivados de 2'-halometiliden, 2'-eteniliden- y 2'-etinil-adenosina.

Info

Publication number
ES2063796T3
ES2063796T3 ES89117735T ES89117735T ES2063796T3 ES 2063796 T3 ES2063796 T3 ES 2063796T3 ES 89117735 T ES89117735 T ES 89117735T ES 89117735 T ES89117735 T ES 89117735T ES 2063796 T3 ES2063796 T3 ES 2063796T3
Authority
ES
Spain
Prior art keywords
adenosine
halometiliden
eteniliden
ethinyl
new derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89117735T
Other languages
English (en)
Inventor
James R Mccarthy
David M Stemerick
Nellikunja J Prakash
Michael L Edwards
Esa T Jarvi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2063796T3 publication Critical patent/ES2063796T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/052—Imidazole radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/056—Triazole or tetrazole radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

ESTE INVENTO RELATA A CIERTOS NUEVOS HALOMETILIDENO-2'', ETENILIDENO-2'' Y DERIVADOS ADENOSINE ETINIL-2'', Y COMPOSICIONES FARMACEUTICAS DE ELLOS, QUE SON UTILES EN INHIBIR LA TRANSMETILACION DEPENDIENTE-ADOMET Y EN EL TRATAMIENTO DE PACIENTES AFLIGIDOS CON ESTADOS NEOPLASTICOS O ENFERMEDADES VIRALES.
ES89117735T 1988-09-27 1989-09-26 Nuevos derivados de 2'-halometiliden, 2'-eteniliden- y 2'-etinil-adenosina. Expired - Lifetime ES2063796T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24991188A 1988-09-27 1988-09-27
US38939189A 1989-08-03 1989-08-03

Publications (1)

Publication Number Publication Date
ES2063796T3 true ES2063796T3 (es) 1995-01-16

Family

ID=26940460

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89117735T Expired - Lifetime ES2063796T3 (es) 1988-09-27 1989-09-26 Nuevos derivados de 2'-halometiliden, 2'-eteniliden- y 2'-etinil-adenosina.

Country Status (18)

Country Link
EP (1) EP0365849B1 (es)
JP (1) JP2968002B2 (es)
KR (1) KR0146333B1 (es)
CN (1) CN1046334A (es)
AR (1) AR248283A1 (es)
AT (1) ATE111477T1 (es)
AU (1) AU621664B2 (es)
CA (1) CA1336903C (es)
DE (1) DE68918215T2 (es)
DK (1) DK171237B1 (es)
ES (1) ES2063796T3 (es)
FI (1) FI94763C (es)
HU (1) HU204843B (es)
IE (1) IE63561B1 (es)
IL (1) IL91773A (es)
NO (1) NO171857C (es)
NZ (1) NZ230766A (es)
PT (1) PT91803B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5206244A (en) * 1990-10-18 1993-04-27 E. R. Squibb & Sons, Inc. Hydroxymethyl (methylenecyclopentyl) purines and pyrimidines
US5340816A (en) * 1990-10-18 1994-08-23 E. R. Squibb & Sons, Inc. Hydroxymethyl(methylenecyclopentyl) purines and pyrimidines
FR2668153B1 (fr) * 1990-10-22 1995-03-31 Pasteur Merieux Serums Vacc Nouveaux composes ribonucleosides, leur procede de preparation et les medicaments les contenant.
US5589587A (en) * 1992-05-12 1996-12-31 Merrell Pharmaceuticals Inc. Process for the preparation of ribonucleotide reductase inhibitors
CA2133961C (en) * 1992-05-12 1998-03-31 James R. Mccarthy A process for the preparation of ribonucleotide reductase inhibitors
US5627053A (en) * 1994-03-29 1997-05-06 Ribozyme Pharmaceuticals, Inc. 2'deoxy-2'-alkylnucleotide containing nucleic acid
US5811408A (en) * 1994-07-12 1998-09-22 Yamasa Corporation 2'-deoxy-2'-(substituted or unsubstituted)methylidene-4'-thionucleosides
WO2000074686A1 (en) * 1999-06-09 2000-12-14 Anticancer, Inc. Modulators of methylation for control of bacterial virulence
US6579857B1 (en) 1999-06-11 2003-06-17 Evanston Northwestern Healthcare Research Institute Combination cancer therapy comprising adenosine and deaminase enzyme inhibitors
KR20040094692A (ko) * 2002-02-14 2004-11-10 파마셋, 리미티드 변형된 불소화 뉴클레오사이드 유사체
UA117095C2 (uk) 2011-12-22 2018-06-25 Аліос Біофарма, Інк. Нуклеозидна сполука або її фармацевтично прийнятна сіль
US9441007B2 (en) 2012-03-21 2016-09-13 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
USRE48171E1 (en) 2012-03-21 2020-08-25 Janssen Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL84414A0 (en) * 1986-11-14 1988-04-29 Ciba Geigy Ag N9-cyclopentyl-substituted adenine derivatives
KR910008800B1 (ko) * 1987-03-19 1991-10-21 야마사 쇼오유 가부시끼가이샤 2'-알킬리덴 피리미딘 누클레오시드 유도체, 그 제조법, 및 그 용도
NZ225906A (en) * 1987-08-26 1990-10-26 Merrell Dow Pharma Aristeromycin/adenosine derivatives and pharmaceutical compositions
ZA894534B (en) * 1988-06-20 1990-03-28 Merrell Dow Pharma Novel neplanocin derivatives

Also Published As

Publication number Publication date
NO171857C (no) 1993-05-12
FI894546A7 (fi) 1990-03-28
FI894546A0 (fi) 1989-09-26
KR900004736A (ko) 1990-04-12
IE63561B1 (en) 1995-05-17
PT91803A (pt) 1990-03-30
EP0365849B1 (en) 1994-09-14
IL91773A0 (en) 1990-06-10
NZ230766A (en) 1992-07-28
IL91773A (en) 1994-02-27
KR0146333B1 (ko) 1998-08-01
NO171857B (no) 1993-02-01
HUT50844A (en) 1990-03-28
CN1046334A (zh) 1990-10-24
EP0365849A3 (en) 1990-12-27
JP2968002B2 (ja) 1999-10-25
IE893080L (en) 1990-03-27
FI94763B (fi) 1995-07-14
DK171237B1 (da) 1996-08-05
DK473289A (da) 1990-03-28
CA1336903C (en) 1995-09-05
DK473289D0 (da) 1989-09-26
AU4176089A (en) 1990-04-05
NO893826L (no) 1990-03-28
NO893826D0 (no) 1989-09-26
DE68918215T2 (de) 1995-02-02
FI94763C (fi) 1995-10-25
DE68918215D1 (de) 1994-10-20
HU204843B (en) 1992-02-28
PT91803B (pt) 1995-05-31
AU621664B2 (en) 1992-03-19
EP0365849A2 (en) 1990-05-02
AR248283A1 (es) 1995-07-12
ATE111477T1 (de) 1994-09-15
JPH02160769A (ja) 1990-06-20

Similar Documents

Publication Publication Date Title
ES2124479T3 (es) Composiciones biocidas.
NO307968B1 (no) Pyrazolo- og pyrrolopyridiner og farmasøytisk blanding derav
MY104685A (en) Substituted thiazoles and their use as fungicides.
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
ES2063796T3 (es) Nuevos derivados de 2'-halometiliden, 2'-eteniliden- y 2'-etinil-adenosina.
ES2056180T3 (es) Nuevos derivados de 2'-halometiliden, 2'-eteniliden y 2'-etinil citidina.
ATE245977T1 (de) Therapeutische substituierte guanidine
AP2000001947A0 (en) Novel crystalline forms of an antiviral benzidazole compound.
ITMI931649A1 (it) Derivati dell'acido 2-ammino-4-fenil-4-osso butirrico
ES2092981T3 (es) Derivados de aristeromicina/adenosina.
MX17877A (es) Composiciones antimalaria y metodos de tratamiento que utilizan quinidina, artemisinina y sus derivados.
DK270789A (da) Hirudin-derivater, deres fremstilling og anvendelse
DK482185D0 (da) Peptider, deres fremstilling og anvendelse som laegemidler
DE58902899D1 (de) 2',3'-dideoxypurinnucleosid/purinnucleosid-phosphorylase-inhibitor kombinationstherapie und zusammensetzungen dafuer.
ES2078904T3 (es) Nuevos derivados de neplanocina.
DK0610078T3 (da) Cytotoksisk og antiviral forbindelse.
NO970573D0 (no) Ylidenforbindelser og deres fremstilling
IT8948640A0 (it) Derivati dell'adenosina, loro preparazione e loro impiego come medicamenti. (caso 100-7409)
DE69128254D1 (de) Antihypertensive benzopyran-derivate
BG102404A (en) The application of flupirtin for the prevention and treatment of diseases related to impairement of the haematopoeic cellular system
GB9505082D0 (en) Medicament
DK0916663T3 (da) 18beta, 19beta-diacetyloxy-18alpha, 19alpha-epoxy-3,13(16), 14-clerodatrien-2-on (Esculentin A) og 18beta, 19beta-diacetyloxy-18alpha, 19alpha-epoxy-3, 12, 14-clerodatrien-2beta-isovaleryloxy-6beta, 7alpha-diol (Esculentin B), fremgangsmåde........
ES2062332T3 (es) Benzoxazolonas antiinflamatorias.
FI956045A0 (fi) Antiparasiittisina aineina käyttökelpoiset 14-substituoidut markfortiinit ja johdannaiset
GR3035004T3 (en) Method and composition for the treatment of herpes related disorders.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 365849

Country of ref document: ES